Obstetrics

Amniocentesis, CVS tests decline despite increase in number of older mothers

Published in Women's Health Weekly, June 24th, 2004

The number of pregnant women undergoing amniocentesis and chorionic villus sampling (CVS) to help detect fetal chromosomal abnormalities such as Down syndrome declined more than 50% between 1991 and 2002, despite the increasing number of pregnant women aged 35 and older, according to a study in the June 2004 issue of Obstetrics & Gynecology.

Although there has been a decline in the number of these two procedures, the number of Down syndrome fetuses detected has increased, mostly due to advances in other non-invasive screening techniques, including nuchal translucency measurement, first- and second-trimester maternal serum screening tests, and second-trimester...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-06-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry